close
MENU
How to guide
How to guide
Home
The NBR Rich List
NBR Marketplace
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Marketing & Media Tourism Energy Luxury Property Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

NBR Marketplace Local Edge NBR Video Toil & Trouble Beehive Banter Morning Brew Dollars & Sense Entrepreneurs The Grind Market Outlook Executive Health Market Review Students’ Say The NBR Podcast Opinion (Archive) NBR Radar (Archive) Private Bin NZ Aviation News (Archive) NBR Rich List (Archive) Your Business Audio Articles The NBR Rich List
Latest
Related
General Business
1

‘No comment’ on FMA rumours about Stobo investigation
General Business
6

The dangerous dreams of John Denize
Primary Industries
6

Fonterra farmers approve $4.2b Lactalis deal
Shoeshine
3

Will Xero make a meal of Melio?
Shoeshine
1

2024 in review: The annual Shoeshine Awards
Shoeshine
2

Supermarkets benevolently swallow the cost of inflation

ANALYSIS: Or do they? Supermarkets and suppliers locked in battle of wits.

Dita De Boni Tue, 27 Sep 2022
Shoeshine
3

Homegrown pharmaceutical firm takes long view

ANALYSIS: Let Douglas Pharmaceuticals not be an outlier in New Zealand’s promising health tech sector.

Maria Slade Mon, 19 Sep 2022
Shoeshine

Earnings season beats expectations but worst is yet to come

ANALYSIS: Headwinds as strong as ever despite listed companies reporting generally positive financial results.

Hamish McNicol Mon, 12 Sep 2022
Shoeshine

The new broom at global health IT provider Orion Health

ANALYSIS: ‘As I say to them, don’t mess it up,’ says founder and former CEO Ian McCrae.

Fiona Rotherham Mon, 05 Sep 2022
Shoeshine

Who are the Edmund Hillary Fellows?

Scheme to boost New Zealand’s entrepreneurial vitality welcomes latest cohort of recruits.

Will Mace Mon, 29 Aug 2022
Shoeshine
5

Another one gets away from the NZX

Partners Life's massive $1b sale should be celebrated, but has left some wondering what could have been.

Hamish McNicol Mon, 22 Aug 2022
Shoeshine
10

Heads bang on desks over builders guarantees

ANALYSIS: Bloody-minded officials put kibosh yet again on mandatory new-build warranties.

Maria Slade Mon, 15 Aug 2022
Shoeshine
6

Following the money

ANALYSIS: The Bioplant group and its offshore partners mum on financing of Manawatū waste-to-energy project.

Fiona Rotherham Mon, 08 Aug 2022
Shoeshine
2

Wherefore art thou IPO?

ANALYSIS: With eight months down, 2022 not looking like a good year for a float.

Will Mace Mon, 01 Aug 2022
1 16 17 18 19 20 58
Most Popular
Most Commented
Investment
1

The top local stocks of 2025

Politics

The committee influencing banks and government performance
General Business

Out of Office Reply: Judith Collins

Rewind 2025: Elevating NZ Inc. – The NBR Rich List
The NBR Podcast

Podcast Summer Series: The view from Australia
General Business
4

New Zealand secures long-sought FTA with India
Finance
48

Just-retired bricklayer ponders loss of $350,000 in Whimp company
Investment
10

FMA warns investors to be ‘fully informed’ on Whimp’s offers
Finance
10

FMA’s Whimp investigation appears warranted, says legal expert
Investment
9

Comvita chair vows to resign if turnaround fails

Politics
9

Government criticised for having the wrong fiscal priorities

Edwards on Politics
9

The IRD’s conduct raises questions about public sector integrity
Subscribe Login